Boston Scientific Corporation : Boston Scientific Receives FDA Approval For ... 4-traders (press release) 25, 2013/PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ Everolimus-Eluting ... |
